Dr. Garrett R. Roll is a surgeon specializing in kidney, liver and pancreas transplantation. He also performs general surgery in patients with end-stage liver and kidney disease, including patients with liver cancer.

Roll received his medical degree from the Lewis Katz School of Medicine at Temple University. He then completed a residency in general surgery and a fellowship in abdominal transplant surgery at UCSF.

After completing his fellowship, Roll was a senior international fellow in liver transplant and retrieval at Queen Elizabeth Hospital Birmingham, home to the busiest liver surgery unit in Europe. During his time in England, he gained experience with normothermic machine perfusion for the liver (NMP-L), a method of preserving the liver as it is transported for transplantation.

Roll's research interests include cell therapy and organ regeneration, NMP-L, and infection with human papilloma virus (HPV) in transplant recipients. He also studies outcomes for transplant patients. He is the primary investigator in a clinical trial of the HPV vaccine for reducing cervical cancer risk in transplant recipients on immunosuppressive drugs.

Roll is a fellow of the American College of Surgeons.

  • Education

    Lewis Katz School of Medicine at Temple University , 2005

  • Residencies

    UCSF Medical Center, general surgery , 2012

  • Fellowships

    UCSF Medical Center, abdominal transplant surgery , 2014

    Queen Elizabeth Hospital, liver transplant and retrieval , 2015

  • Board Certifications

    Surgery, American Board of Surgery

  • Academic Title

    Assistant Professor

Our division offers options to patients with organ failure who may have been told elsewhere they had none.

Kidney Transplant Center

400 Parnassus Ave., Seventh Floor
San Francisco, CA 94143

Liver Transplant Program

400 Parnassus Ave., Third Floor
San Francisco, CA 94143

Selected research

Decorative Caduceus

OCS Liver PROTECT Continued Access Protocol

Incidence of early allograft dysfunction or primary non-function of donor liver

Recruiting

Share